Osaic Holdings
TARA icon

Osaic Holdings’s Protara Therapeutics TARA Stock Holding History

Osaic Holdings’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$382 Hold
100
– – ﹤0.01% 7700
2026
Q1 		$521 Hold
100
– – ﹤0.01% 7426
2025
Q4 		$533 Hold
100
– – ﹤0.01% 7429
2025
Q3 		$312 Hold
100
– – ﹤0.01% 7631
2025
Q2 		$303 Hold
100
– – ﹤0.01% 7448
2025
Q1 		$426 Hold
100
– – ﹤0.01% 7031
2024
Q4 		$528 Hold
100
– – ﹤0.01% 7010
2024
Q3 		$183 Hold
100
– – ﹤0.01% 7191
2024
Q2 		$208 Hold
100
– – ﹤0.01% 7163
2024
Q1 		$401 Hold
100
– – ﹤0.01% 6861
2023
Q4 		$188 Hold
100
– – ﹤0.01% 7053
2023
Q3 		$167 Hold
100
– – ﹤0.01% 7180
2023
Q2 		$239 Hold
100
– – ﹤0.01% 7174
2023
Q1 		$313 Hold
100
– – ﹤0.01% 7209
2022
Q4 		$268 Buy
+100
New +$316 ﹤0.01% 7103
2022
Q1 		– Sell
-174
Closed -$1K – 7490
2021
Q4 		$1K Sell
174
-2,426
-93% -$16.7K ﹤0.01% 7249
2021
Q3 		$18K Buy
+2,600
New +$20.3K ﹤0.01% 5855

Other funds holding TARA

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return

Osaic Holdings's TARA Position: Q2 2026 in Review

Osaic Holdings held its Protara Therapeutics (TARA) position steady in Q2 2026 at 100 shares worth $382. The position accounts for ﹤0.01% of the portfolio, ranked #7700.

Osaic Holdings first reported a position in TARA in Q3 2021 and has held it in 17 quarters since. The position peaked at $18K in Q3 2021. 119 funds tracked by Wall St. Rank hold TARA as of Q2 2026.

  • Osaic Holdings held 100 shares of Protara Therapeutics worth $382 as of Q2 2026.
  • Osaic Holdings left its Protara Therapeutics share count unchanged in Q2 2026.
  • Protara Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7700 holding.
  • Osaic Holdings first reported a position in Protara Therapeutics in Q3 2021 and has held it in 17 quarters since.
  • Osaic Holdings's Protara Therapeutics position peaked at $18K in Q3 2021.
  • 119 funds tracked by Wall St. Rank held Protara Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.